D&D Pharmatech Revenue

In the year 2025, D&D Pharmatech had annual revenue of 4.30B KRW, down -62.42%. D&D Pharmatech had revenue of 990.09M in the quarter ending December 31, 2025, a decrease of -80.42%.

Revenue

4.30B

Revenue Growth

-62.42%

P/S Ratio

802.16

Revenue / Employee

n/a

Employees

n/a

Market Cap

3,447.39B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.30B	-7.14B	-62.42%
Dec 31, 2024	11.44B	-7.24B	-38.77%
Dec 31, 2023	18.68B	18.07B	2,958.97%
Dec 31, 2022	610.57M	-753.54M	-55.24%
Dec 31, 2021	1.36B	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SK bioscience	651.37B
OliX Pharmaceuticals	14.67B
PharmaResearch	536.29B
Hugel	425.11B
Voronoi	7.51B
Peptron	5.63B
Orum Therapeutics	23.56M
LigaChem Biosciences	141.55B

Revenue Rankings